Molecular Modelling and Dynamics Study of nsSNP in STXBP1 Gene in Early Infantile Epileptic Encephalopathy Disease

Krami Al Mehdi1,2, Benhnini Fouad3, Elkarhat Zouhair1

  • 1Laboratory of Genomics and Human Genetics, Institut Pasteur du Maroc, Casablanca 20360, Morocco.

Insights

This study identifies 11 high-risk STXBP1 gene variants linked to early infantile epileptic encephalopathy. These genetic changes significantly impact Stxbp1 protein structure and stability, aiding in patient screening.

Area of Science:

  • Genetics and Molecular Biology
  • Neuroscience
  • Bioinformatics

Background:

  • Early Infantile Epileptic Encephalopathy (Ohtahara Syndrome) is a severe epilepsy form with early seizure onset in newborns and young children.
  • The STXBP1 gene, encoding Syntaxin binding protein 1a, is implicated in synaptic vesicle exocytosis and associated with early infantile epileptic encephalopathy.

Purpose of the Study:

  • To identify pathogenic polymorphisms in the STXBP1 gene.
  • To determine the impact of these polymorphisms on the structure and stability of the Stxbp1 protein.

Main Methods:

  • Utilized 13 bioinformatics tools to predict high-risk nonsynonymous single nucleotide polymorphisms (nsSNPs) in the STXBP1 gene.
  • Performed conservation analysis using the CONSURF web server.
  • Assessed the impact on protein structure with YASARA software and conducted molecular dynamics simulations using GROMACS.

Main Results:

  • Identified 11 deleterious nsSNPs (S42P, H103D, R190W, R235G, D238E, L256P, P335S, C354Y, L365V, R406C, G544D) out of 245 analyzed.
  • Conservation analysis confirmed these nsSNPs are located in conserved regions.
  • Structural analysis and molecular dynamics simulations revealed that these nsSNPs adversely affect Stxbp1 protein structure, stability, residual fluctuation, and compaction.

Conclusions:

  • This study pinpoints high-risk nsSNPs in STXBP1 that can alter Stxbp1 protein structure and function.
  • These identified variants are crucial for consideration in the genetic screening of patients with early infantile epileptic encephalopathy.

Related Concept Videos